Articles from Kimba

Today, sleep technology company Kimba announced its launch and $6.5 million funding round led by Selva Ventures, introducing a clinically validated, AI-powered approach to improving sleep through adaptive scent therapy. Developed alongside leading sleep and neuroscience researchers, Kimba sits at the intersection of consumer health and sleep science and is designed to actively improve sleep rather than simply track it. By using the olfactory pathway, the only sensory channel capable of influencing the brain during sleep without causing wakefulness, Kimba delivers personalized scent interventions designed to support deeper, more restorative rest without drugs or disruption.